Codiak Biosciences Competitors and Similar CompaniesClear all
Codiak Biosciences's competitors and similar companies include Nimbus Therapeutics, ArunA Bio and Evox Therapeutics.
 Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. |  Nimbus Therapeutics Nimbus Therapeutics is a biotechnology company which operates an application of computational chemistry to design treatments for substantial and underserved human diseases. |  ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. |  Evox Therapeutics Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies. | |
Founding Date | Founding Date 2015 | Founding Date 2009 | Founding Date 2003 | Founding Date 2016 |
Type | Type Public | Type Private | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Cambridge, US HQ | Locations Cambridge, US HQ | Locations Athens, US HQ Athens, US | Locations Oxford, GB HQ |
Employees | Employees 992% decrease | Employees 1091% increase | Employees 274% increase | Employees 452% decrease |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 105m (almost 5 years ago) | Latest funding round $ 4.5m (over 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 168.5m | Total funding raised $ 242m | Total funding raised $ 26.9m | Total funding raised $ 158.6m |
For sources of this data, please see the company profile
View Company Profiles
Nimbus Therapeutics
HQ
Cambridge, US
Employees
109↑ 1% increase
Nimbus Therapeutics is a biotechnology company which operates an application of computational chemistry to design treatments for substantial and underserved human diseases.
View companyArunA Bio
HQ
Athens, US
Employees
27↑ 4% increase
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
View companyEvox Therapeutics
HQ
Oxford, GB
Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies.
View company